Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Junshi Biosciences
Pharma
Pfizer partner touts HER2 ADC trial win in bladder cancer
RemeGen's China readout bodes well for Pfizer’s own global phase 3 trial that pairs disitamab vedotin with Keytruda in first-line bladder cancer.
Angus Liu
May 12, 2025 10:59am
Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia
Jan 24, 2025 8:55am
Leo bags Loqtorzi rights, putting marketing muscle behind launch
Jan 21, 2025 11:15am
AbbVie-FutureGen, Takeda, Kyowa Kirin—Fierce Pharma Asia
Jun 14, 2024 5:00am
Junshi, Coherus move Loqtorzi closer to another approval
Jun 12, 2024 11:45am
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
Dec 1, 2023 8:34am
